Welcome to Medications.com

Ranbaxy: Tough times - Business Standard

Over the next few quarters, growth for the company is also expected from authorised generics sales for the product Isoptin (medication for treating heart ...

http://www.business-standard.com/... | Posted: Fri Oct 19 11:16:59 -0400 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea